Lili Huang

发表

Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial.

D. Qu, Yongli Yang, Zhenghong Yuan, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.

Shuai Wang, Wei Zhang, S. Xia, 2021, Vaccine.

Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial

P. Qiu, Xiaoyu Cui, Li-yong Yuan, 2019, Human vaccines & immunotherapeutics.

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.

Yongli Yang, Shuai Wang, Feilong Gao, 2022, Vaccine.

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

Wei Zhou, S. Shen, Xiaoming Yang, 2022, Frontiers in Immunology.

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

J. Xia, Q. Ye, Jing Li, 2018, Human vaccines & immunotherapeutics.

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.

Yongli Yang, A. Pan, S. Shen, 2020, JAMA.

Molecular Characterization and Antimicrobial Susceptibility of Salmonella Isolates from Infections in Humans in Henan Province, China

F. Aarestrup, Bian-Li Xu, R. Hendriksen, 2008, Journal of Clinical Microbiology.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Wenling Wang, Baoying Huang, Wenbo Xu, 2020, The Lancet Infectious Diseases.

Emergence of a New Multidrug-Resistant Serotype X Variant in an Epidemic Clone of Shigella flexneri

Zhemin Zhou, R. Lan, X. Bai, 2009, Journal of Clinical Microbiology.

China, in 2006 Infections in Henan Province, Shigellaand Characterization of Human

F. Aarestrup, Bian-Li Xu, C. Pulsrikarn, 2012 .

Prevalence and Characterization of Human Shigella Infections in Henan Province, China, in 2006

F. Aarestrup, Bian-Li Xu, R. Hendriksen, 2010, Journal of Clinical Microbiology.

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

W. Wang, Wenling Wang, Baoying Huang, 2021, The Lancet Infectious Diseases.

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years

Lei Wang, Fanhong Meng, N. Jia, 2022, Vaccines.

Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.

Bian-Li Xu, Yueyue Liu, T. Guo, 2020, Vaccine.

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

Wenhui Zhang, Jianhua Yu, Shourong Liu, 2023, Frontiers in Immunology.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial

A. Pan, S. Shen, Xiaoming Yang, 2021, EClinicalMedicine.

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study

Jiayou Zhang, Xiaoming Yang, Kai Duan, 2023, Human vaccines & immunotherapeutics.